December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Review of precision therapeutics and emerging strategies in HR+ MBC
Aug 27, 2024, 17:21

Review of precision therapeutics and emerging strategies in HR+ MBC

Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X:

Congratulations to Maxwell Lloyd, Kevin Kalinsky, Aditya Bardia, Komal Jhaveri and Seth Wander for recently published review of precision therapeutics and emerging strategies in HR+ MBC (metastatic breast cancer) in Nature Reviews Clinical Oncology.

Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer

Authors: Maxwell Lloyd, Kevin Kalinsky, Aditya Bardia, Komal Jhaveri and Seth Wander.

Review of precision therapeutics and emerging strategies in HR+ MBC

Source: Michelle DeMeo/X